Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 22,513Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6GENZYME CORP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Pharma Manufacturing 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2031-01-31

ELIGLUSTAT TARTRATE

US Patent Number : 10888547

Drug Substance Claim :

Drug Product Claim :

Application Number : 205494

Patent Use Code : U-3042

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-01-31

Sanofi Company Banner

02

arrow
Pharma Manufacturing 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2031-01-31

ELIGLUSTAT TARTRATE

US Patent Number : 10888547

Drug Substance Claim :

Drug Product Claim :

Application Number : 205494

Patent Use Code : U-3043

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-01-31

Sanofi Company Banner

03

arrow
Pharma Manufacturing 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2038-12-13

ELIGLUSTAT TARTRATE

US Patent Number : 10888544

Drug Substance Claim :

Drug Product Claim :

Application Number : 205494

Patent Use Code : U-3041

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-12-13

Sanofi Company Banner

04

arrow
Pharma Manufacturing 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2038-12-13

ELIGLUSTAT TARTRATE

US Patent Number : 10888544

Drug Substance Claim :

Drug Product Claim :

Application Number : 205494

Patent Use Code : U-3040

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-12-13

Sanofi Company Banner

05

arrow
Pharma Manufacturing 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2026-06-26

ELIGLUSTAT TARTRATE

US Patent Number : 7196205

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 205494

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-06-26

Sanofi Company Banner

06

arrow
Pharma Manufacturing 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2030-11-24

ELIGLUSTAT TARTRATE

US Patent Number : 11458119

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 205494

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-11-24

Sanofi Company Banner